Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) 3-Year Book Growth Rate : -13.80% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Staidson (Beijing) Biopharmaceuticals Co 3-Year Book Growth Rate?

Staidson (Beijing) Biopharmaceuticals Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥2.15.

During the past 12 months, Staidson (Beijing) Biopharmaceuticals Co's average Book Value per Share Growth Rate was -19.70% per year. During the past 3 years, the average Book Value per Share Growth Rate was -13.80% per year. During the past 5 years, the average Book Value per Share Growth Rate was -13.30% per year. During the past 10 years, the average Book Value per Share Growth Rate was -2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Staidson (Beijing) Biopharmaceuticals Co was 129.00% per year. The lowest was -14.20% per year. And the median was 11.85% per year.

Competitive Comparison of Staidson (Beijing) Biopharmaceuticals Co's 3-Year Book Growth Rate

For the Biotechnology subindustry, Staidson (Beijing) Biopharmaceuticals Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Staidson (Beijing) Biopharmaceuticals Co's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Staidson (Beijing) Biopharmaceuticals Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Staidson (Beijing) Biopharmaceuticals Co's 3-Year Book Growth Rate falls into.

Staidson (Beijing) Biopharmaceuticals Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Staidson (Beijing) Biopharmaceuticals Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Staidson (Beijing) Biopharmaceuticals Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Staidson (Beijing) Biopharmaceuticals Co Ltd (SZSE:300204) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rongjing Dong Street, No 5 Beijing Economic and Technological Development Zone, Beijing, CHN, 100176

Website

http://www.staidson.com

Staidson (Beijing) Biopharmaceuticals Co Ltd is a pharmaceutical company mainly engaged in the research, development, production, and sale of biological products in China. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin.

Executives

Zhang Hong Shan	Supervisors
Zheng Hong	Supervisors
Cheng Jiang Hong	Executives
Feng Yu Jing	Executives
Ma Li Na	Secretary, Director
Zhou Zhi Wen	Director
Wang Huan	Securities Affairs Representative
Zhang Rong Qin	Executives
Xu Jiang Ping	Executives
Cao Hai Yan	Supervisors
Sun Yan Fang	Executives
Jiang Li Xin	Director
Gu Jian Ping	Director
Xu Xiang Qing	Supervisors
Gu Zhen Qi	Director

Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Headlines

No Headlines